I hold this stock and I don't like jumping back and forth at all. That's not my style of trading. I buy good stocks and if I have a loss in my account = no matter
I wait patiently and then I wait for a profit and I sit back and watch and sometimes it works - sometimes it doesn't
and that's why I always hold shares for a longer period of time (for example, I went into $FORW a long time ago at 0.0072 and when this share fell back to 0.005 I still wasn't afraid and just held on to my shares and now a few days later it's starting to go up and I'm sitting back and watching what happens in 2025 and for a few days it's been steadily going up So
I think back and forth is bad and bigger profits. You do that if you look for good shares and hold on a little longer, but. "everyone should trade in a way that makes them happy. that's the most important thing") $SXTC was also played down and I have losses there too but with this small structure this China share can explode upwards every day and here too I wait and don't jump out again - just because I have a 30% loss in my account and if it doesn't work out, everyone knows the risk on the stock market
in principle we all speculate on the stock market and everyone in their own way. and everyone thinks his style is the best and I kept my nerve and think it was good to just hold on to $TVGN for a while and keep my nerve and not always jump in and out,
all only imho
I wait patiently and then I wait for a profit and I sit back and watch and sometimes it works - sometimes it doesn't
and that's why I always hold shares for a longer period of time (for example, I went into $FORW a long time ago at 0.0072 and when this share fell back to 0.005 I still wasn't afraid and just held on to my shares and now a few days later it's starting to go up and I'm sitting back and watching what happens in 2025 and for a few days it's been steadily going up So
I think back and forth is bad and bigger profits. You do that if you look for good shares and hold on a little longer, but. "everyone should trade in a way that makes them happy. that's the most important thing") $SXTC was also played down and I have losses there too but with this small structure this China share can explode upwards every day and here too I wait and don't jump out again - just because I have a 30% loss in my account and if it doesn't work out, everyone knows the risk on the stock market
in principle we all speculate on the stock market and everyone in their own way. and everyone thinks his style is the best and I kept my nerve and think it was good to just hold on to $TVGN for a while and keep my nerve and not always jump in and out,
all only imho
Recent TVGN News
- Tevogen Advances Strategic CRO Evaluation to Expand Clinical Research Delivery Capabilities and Drive Revenue Growth • GlobeNewswire Inc. • 03/26/2026 04:45:00 PM
- Tevogen Regains Compliance with Nasdaq Minimum Bid Price Requirement • GlobeNewswire Inc. • 03/25/2026 06:20:00 PM
- Tevogen CIO and Head of Tevogen.AI Mittul Mehta to Speak at Microsoft Fabric Community Conference (FabCon 2026) • GlobeNewswire Inc. • 03/18/2026 04:22:11 PM
- Tevogen Reaffirms Capital Discipline as Lead Investor Maintains Holdings and Company Limits Share Utilization • GlobeNewswire Inc. • 03/13/2026 06:45:00 PM
- Tevogen.AI Reports Advancements in PredicTcell™ Beta, Demonstrates Improved Precision Metrics and Expands Proprietary AI Infrastructure • GlobeNewswire Inc. • 03/13/2026 04:30:00 PM
- Tevogen CEO Dr. Ryan Saadi Reaffirms Clinical Commitment During International Long COVID Awareness Month; Highlights Synergies of New Leadership Team and Digital Care Platform • GlobeNewswire Inc. • 03/11/2026 07:15:00 PM
- Tevogen Names Leadership Team to Execute Diversified Growth Strategy • GlobeNewswire Inc. • 03/09/2026 11:45:00 AM
- Letter to Shareholders from CEO Dr. Ryan Saadi • GlobeNewswire Inc. • 03/06/2026 08:40:00 PM
- Tevogen Advances Generics Strategy, Signs Letter of Intent to Evaluate Potential Acquisition of Apozeal Pharmaceutical • GlobeNewswire Inc. • 03/05/2026 07:50:00 PM
- Tevogen Bio to implement 1-for-50 reverse stock split to regain Nasdaq compliance • IH Market News • 03/04/2026 03:47:21 PM
- Tevogen Announces Reverse Stock Split • GlobeNewswire Inc. • 03/04/2026 01:00:00 PM
- Tevogen Signs Letter of Intent to Evaluate Potential Acquisition of a Contract Research Organization • GlobeNewswire Inc. • 02/27/2026 07:20:00 PM
- UPDATE - Tevogen Signs Letter of Intent to Evaluate Potential Acquisition of Sciometrix and its Digital Care Management Platform Clinicus • GlobeNewswire Inc. • 02/26/2026 09:22:45 PM
- Tevogen Signs Letter of Intent to Evaluate Potential Acquisition of Sciometrix and its Digital Care Management Platform Clinicus • GlobeNewswire Inc. • 02/26/2026 02:20:00 PM
- Tevogen Board to Evaluate Potential One-Time Special Cash Dividend to Shareholders • GlobeNewswire Inc. • 01/30/2026 08:00:00 PM
- Tevogen to Align Long-Term Stock-Based Incentive Program With Company Milestones, Including Revenue • GlobeNewswire Inc. • 01/29/2026 07:45:00 PM
- Tevogen Demonstrates Platform Scalability and Multi-Indication T Cell Pipeline Expansion in 2025 • GlobeNewswire Inc. • 01/12/2026 02:00:00 PM
- Tevogen CEO Donates Shares to Support Education for Underprivileged Children • GlobeNewswire Inc. • 12/22/2025 05:40:00 PM
- Tevogen CEO Donates Personal Shares to Support Local Fire Department • GlobeNewswire Inc. • 12/19/2025 04:10:00 PM
- Tevogen CEO Supports Local Law Enforcement with Personal Contribution of 230,000 Company’s Shares of Common Stock • GlobeNewswire Inc. • 12/11/2025 08:15:00 PM
- Tevogen Celebrates Board Member Dr. Curtis Patton, Honored by Yale University for Distinguished Career and Lasting Contributions to Medical Education and Equity in Medicine • GlobeNewswire Inc. • 12/09/2025 07:20:00 PM
- Tevogen Recognized on 2025 NJBIZ Power List Amid Growth and Multi-Billion-Dollar Revenue Outlook • GlobeNewswire Inc. • 12/08/2025 07:50:00 PM
- Tevogen Highlights Continued Capital Efficiency Following Filing of Q3 2025 Form 10-Q • GlobeNewswire Inc. • 11/14/2025 07:32:37 PM
- Tevogen Reports Major Clinical Milestone: Expands HLA Coverage of its Investigational Precision T Cell Therapy for Acute and Long COVID • GlobeNewswire Inc. • 11/05/2025 08:20:00 PM
- Tevogen Clarifies Reported Financials, Highlighting Strong Capital Efficiency and Low Cash Burn • GlobeNewswire Inc. • 11/03/2025 07:45:00 PM
